ArticleActa pharmacologica Sinica2025

Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin.

Ya-Li Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.